The Development of Upper Extremity Rehabilitation Program Using Virtual Reality for the Stroke Patients
Study Details
Study Description
Brief Summary
Using the upper extremity rehabilitation program developed by virtual reality would help the recovery upper extremity function in patients with stroke.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
This randomized, double-blind, controlled trial included 24 patients with ischemic stroke. The intervention group received 30 min of conventional occupational therapy (OT) and 30 min of the mobile upper extremity rehabilitation program using a smartphone and a tablet PC (MoU-Rehab). The controls (n = 12) received conventional OT alone for 1 h per day. Rehabilitation consisted of 10 sessions of therapy, 5 days per week, for 2 weeks. The outcome measures (Fugl-Meyer Assessment of the upper extremity [FMA-UE], Brunnstr¨om stage [B-stage] for the arm and the hand, manual muscle testing [MMT], modified Barthel index [MBI], EuroQol-5 Dimension [EQ-5D], and Beck Depression Inventory [BDI]) were assessed at the beginning and end of treatment, and at 1 month. User satisfaction was evaluated by a qestionnaire.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Virtual reality program mobile device for virtual reality program |
Other: Virtual reality program for upper extremity rehabilitation
|
| Active Comparator: Control standard occupuational therapy |
Other: standard occupational therapy
|
Outcome Measures
Primary Outcome Measures
- Fugl-Meyer upper extremity scale [baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks]
for motor evaluation
Secondary Outcome Measures
- brunnström stage [baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks]
for motor evaluation
- Modified Barthel Index [baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks]
for ADL independence
- Medical Research Council (MRC) Scale for Muscle Strength [baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks]
for motor evaluation
- Euroqol(EQ)-5D [baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks]
EQ-5D
- Virtual reality kinematic data [everytime when the patient uses program (automatically all recorded)]
Automatically recorded
- questionnaire [at the end of the treatment for 2 weeks]
for user satisfaction
Eligibility Criteria
Criteria
Inclusion Criteria:
-
ischemic or hemorrhagic stroke confirmed by brain imaging study
-
upper extremity dysfunction
-
possible to use a simple device
Exclusion Criteria:
-
delirium, confusion or other evidence related to the consciousness
-
uncontrolled medical or surgical disease
-
unable to command to the order due to severe cognitive impairment
-
visual impairment
-
unable to sit
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do | Korea, Republic of | 463-707 |
Sponsors and Collaborators
- Seoul National University Bundang Hospital
Investigators
- Principal Investigator: Nam-Jong Paik, Ph.D, Seoul National University Bundang Hospital, Seongnam, South Korea
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- B-1306/208-005